PDE4-IN-26
PDE4-IN-26 (Compound A5) is an orally bioavailable, selective PDE4 inhibitor with anti-inflammatory action via p38 MAPK inhibition. It has demonstrated efficacy in preclinical models of acute lung injury and COPD, reducing inflammation, fibrosis, and damage while promoting mucociliary clearance.
Product Specifications
Field of Research
Metabolism Research, Signal Transduction
Molecular Formula
C22H18F2N4O3S
Molecular Weight
456.47
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PO55213M2 100 µg
SARS-CoV-2 (2019-nCoV) Spike RBD (V395I) -His Recombinant Protein
Sign In for Pricing
View Details 
RC222774L1 10 µg
p38 (MAPK14) (NM_139014) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details